143 related articles for article (PubMed ID: 34689678)
21. [Delayed endolymphatic hydrops].
Giannoni B; Pagnini P; Vannucchi P
Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
[TBL] [Abstract][Full Text] [Related]
22. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
23. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
Barbara M; Consagra C; Monini S; Nostro G; Harguindey A; Vestri A; Filipo R
Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
[TBL] [Abstract][Full Text] [Related]
24. In response to systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Wang Y
Laryngoscope; 2015 Dec; 125(12):E391. PubMed ID: 25994452
[No Abstract] [Full Text] [Related]
25. In reference to systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Syed MI; Rutka J
Laryngoscope; 2015 Dec; 125(12):E390. PubMed ID: 25993911
[No Abstract] [Full Text] [Related]
26. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
27. [Local overpressure treatment reduces vestibular symptoms in patients with Menière's disease--secondary publication. A clinically randomised multicenter double-blind placebo-controlled study].
Thomsen JC; Sass K; Odkvist L; Arlinger S
Ugeskr Laeger; 2006 Jan; 168(4):378-80. PubMed ID: 16436239
[TBL] [Abstract][Full Text] [Related]
28. Summating potential and action potential ratio in Meniere's disease before and after treatment.
Orchik DJ; Shea JJ; Ge NN
Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of endolymphatic sac drainage with local steroids for intractable Meniere's disease.
Kitahara T; Fukushima M; Uno A; Imai T; Ohta Y; Morihana T; Kamakura T; Horii A; Inohara H
Auris Nasus Larynx; 2013 Oct; 40(5):425-30. PubMed ID: 23273764
[TBL] [Abstract][Full Text] [Related]
30. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
31. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease?
Boudewyns AN; Wuyts FL; Hoppenbrouwers M; Ketelslagers K; Vanspauwen R; Forton G; Van de Heyning PH
Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675
[TBL] [Abstract][Full Text] [Related]
32. Progression of endolymphatic hydrops and vertigo during treatment in Meniere's disease.
Niu Y; Chen W; Lin M; Sha Y
Acta Otolaryngol; 2022; 142(9-12):653-657. PubMed ID: 36369788
[TBL] [Abstract][Full Text] [Related]
33. Prevention of vertigo in Ménière's syndrome by means of transtympanic ventilation tubes.
Montandon P; Guillemin P; Häusler R
ORL J Otorhinolaryngol Relat Spec; 1988; 50(6):377-81. PubMed ID: 3231460
[TBL] [Abstract][Full Text] [Related]
34. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops.
Yazdi AK; Rutka J
J Otolaryngol; 1996 Feb; 25(1):26-31. PubMed ID: 8816106
[TBL] [Abstract][Full Text] [Related]
35. P-100 in the treatment of Ménière's disease: a clinical study.
Franz B; van der Laan F
Int Tinnitus J; 2005; 11(2):146-9. PubMed ID: 16639914
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of cochlear Ménière's disease with electrocochleography.
Dornhoffer JL
ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):301-5. PubMed ID: 9742276
[TBL] [Abstract][Full Text] [Related]
37. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
38. Delayed endolymphatic hydrops. Special emphasis on nystagmus associated with episodes and contribution of chemical labyrinthectomy.
Reynard P; Karkas A; Gavid M; Lelonge Y; Bertholon P
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Oct; 135(5):321-326. PubMed ID: 30172621
[TBL] [Abstract][Full Text] [Related]
39. Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Menière's disease patients?
Claes G; Van den Hauwe L; Wuyts F; Van de Heyning P
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):413-8. PubMed ID: 21626123
[TBL] [Abstract][Full Text] [Related]
40. Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.
Liu B; Leng Y; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
Medicine (Baltimore); 2016 Dec; 95(52):e5767. PubMed ID: 28033296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
